Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry M Elliott

Showing results (121-130 of 292) with videos related to

Pageof 30
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 10, 2009
Right ventricular hypertrabeculation associated with double-outlet left ventricle: exaggeration of a normal pattern or right ventricular cardiomyopathy?Giuseppe Limongelli, Giuseppe Pacileo, Paolo Calabro', et al.
European Heart Journal|March 5, 2013
Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathyCaroline J Coats, Mathew J Gallagher, Michael Foley, et al.
International Journal of Cardiology|May 28, 2003
Subclinical skeletal muscle abnormalities in patients with hypertrophic cardiomyopathy and their relation to clinical characteristicsAris Anastasakis, Nikos Karandreas, Pantelis Stathis, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 15, 2011
Impact of measures to enhance the value of observational surveys in rare diseases: the Fabry Outcome Survey (FOS)Joe T R Clarke, Roberto Giugliani, Gere Sunder-Plassmann, et al.
European Heart Journal|December 27, 2011
Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathyGiovanni Quarta, Petros Syrris, Michael Ashworth, et al.
European Journal of Heart Failure|April 15, 2008
Effect of biventricular pacing on symptoms and cardiac remodelling in patients with end-stage hypertrophic cardiomyopathyDominic P S Rogers, Stefania Marazia, Anthony W Chow, et al.
The American Journal of Cardiology|August 9, 2006
Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathyRajesh Thaman, Maite Tome Esteban, Sophie Barnes, et al.
European Heart Journal|December 4, 2003
Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitiumJames C C Moon, Bhavesh Sachdev, Andrew G Elkington, et al.
Journal of the American College of Cardiology|June 25, 2011
Exercise-induced left ventricular outflow tract obstruction in symptomatic patients with Anderson-Fabry diseaseMargherita Calcagnino, Constantinos O'Mahony, Caroline Coats, et al.
Circulation. Arrhythmia and Electrophysiology|April 15, 2017
Disease Severity and Exercise Testing Reduce Subcutaneous Implantable Cardioverter-Defibrillator Left Sternal ECG Screening Success in Hypertrophic CardiomyopathyNeil T Srinivasan, Kiran H Patel, Kashif Qamar, et al.
Pageof 30

Showing results (121-130 of 292) with videos related to

Sort By:
Pageof 30
Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 10, 2009
Right ventricular hypertrabeculation associated with double-outlet left ventricle: exaggeration of a normal pattern or right ventricular cardiomyopathy?Giuseppe Limongelli, Giuseppe Pacileo, Paolo Calabro', et al.
European Heart Journal|March 5, 2013
Relation between serum N-terminal pro-brain natriuretic peptide and prognosis in patients with hypertrophic cardiomyopathyCaroline J Coats, Mathew J Gallagher, Michael Foley, et al.
International Journal of Cardiology|May 28, 2003
Subclinical skeletal muscle abnormalities in patients with hypertrophic cardiomyopathy and their relation to clinical characteristicsAris Anastasakis, Nikos Karandreas, Pantelis Stathis, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 15, 2011
Impact of measures to enhance the value of observational surveys in rare diseases: the Fabry Outcome Survey (FOS)Joe T R Clarke, Roberto Giugliani, Gere Sunder-Plassmann, et al.
European Heart Journal|December 27, 2011
Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathyGiovanni Quarta, Petros Syrris, Michael Ashworth, et al.
European Journal of Heart Failure|April 15, 2008
Effect of biventricular pacing on symptoms and cardiac remodelling in patients with end-stage hypertrophic cardiomyopathyDominic P S Rogers, Stefania Marazia, Anthony W Chow, et al.
The American Journal of Cardiology|August 9, 2006
Usefulness of N-terminal pro-B-type natriuretic peptide levels to predict exercise capacity in hypertrophic cardiomyopathyRajesh Thaman, Maite Tome Esteban, Sophie Barnes, et al.
European Heart Journal|December 4, 2003
Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitiumJames C C Moon, Bhavesh Sachdev, Andrew G Elkington, et al.
Journal of the American College of Cardiology|June 25, 2011
Exercise-induced left ventricular outflow tract obstruction in symptomatic patients with Anderson-Fabry diseaseMargherita Calcagnino, Constantinos O'Mahony, Caroline Coats, et al.
Circulation. Arrhythmia and Electrophysiology|April 15, 2017
Disease Severity and Exercise Testing Reduce Subcutaneous Implantable Cardioverter-Defibrillator Left Sternal ECG Screening Success in Hypertrophic CardiomyopathyNeil T Srinivasan, Kiran H Patel, Kashif Qamar, et al.
Pageof 30